Fiona E. Scott
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Radiopharmaceutical Chemistry and Applications, HER2/EGFR in Cancer Research, Glycosylation and Glycoproteins Research, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Molecular imaging of T cell co-regulator factor B7-H3 with 89Zr-DS-5573a(2018)59 cited
- → Thalidomide as therapy for primary biliary cirrhosis: a double-blind placebo controlled pilot study(1994)52 cited
- → Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer(2015)37 cited
- → Targeted Chemoradiation in Metastatic Colorectal Cancer: A Phase I Trial of 131I-huA33 with Concurrent Capecitabine(2014)30 cited
- → Fibroblast activation protein increases metastatic potential of fibrosarcoma line HT1080 through upregulation of integrin-mediated signaling pathways(2015)28 cited
- → A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers(2022)24 cited
- → Radiolabelling and preclinical characterization of 89Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa(2021)24 cited
- → First clinical study of a pegylated diabody 124I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancers(2020)24 cited
- → A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls(2021)20 cited
- → Expression of EGFR and conformational forms of EGFR in malignant pleural mesothelioma and its impact on survival(2020)14 cited